Not Medicare Enrolled

Dr. Randall Reese, MD

Pediatrics · Gulf Breeze, FL
Low-engagement
1368 COUNTRY CLUB RD, Gulf Breeze, FL 32563
8509349876
In practice since 2006 (19 years)
NPI: 1285718676 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reese? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reese

Dr. Randall Reese is a pediatrics specialist in Gulf Breeze, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Reese received a total of $2,485 from 25 pharmaceutical and/or device companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reese is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $2,485 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 74566 Clear January 31, 2028 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$2,485
Total received (2018-2024)
Avg $355/year across 7 years
Top 6% in FL for pediatrics
25
Companies
145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,438 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$461
2023
$338
2022
$419
2021
$282
2020
$252
2019
$496
2018
$236

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$379
Neos Therapeutics, LP
$313
Takeda Pharmaceuticals U.S.A., Inc.
$278
Tris Pharma Inc
$256
Corium, LLC
$248
PFIZER INC.
$153
GlaxoSmithKline, LLC.
$114
SANOFI PASTEUR INC.
$112
Ironshore Pharmaceuticals Inc.
$86
Tempus AI, Inc
$66
Verrica Pharmaceuticals Inc.
$65
Eli Lilly and Company
$58
Merck Sharp & Dohme LLC
$51
IRONSHORE PHARMACEUTICALS INC.
$41
Sanofi Pasteur Inc.
$41
Genentech USA, Inc.
$34
AstraZeneca Pharmaceuticals LP
$31
Adlon Therapeutics L.P.
$25
ARBOR PHARMACEUTICALS, INC.
$25
Shire North American Group Inc
$24
Seqirus USA Inc
$23
ACADIA Pharmaceuticals Inc
$19
Vertical Pharmaceuticals, LLC
$15
Merck Sharp & Dohme Corporation
$14
Mission Pharmacal Company
$13
Top 3 companies account for 39.0% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AZSTARYS · Adzenys XR-ODT · Azstarys · BEXSERO · BEYFORTUS · CIBINQO · Cotempla XR-ODT · DAYBUE · Dyanavel XR · EUCRISA · FLUMIST · FLUMIST QUADRIVALENT · FLUZONE HIGH-DOSE · Flucelvax · GARDASIL 9 · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · MENACTRA · Otovel · PENTACEL · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prednisolone 25 · QELBREE · QUADRACEL · Qelbree · Quillichew ER · Quillivant · Quillivant XR · RELEXXII · ROTATEQ · TRUMENBA · VAXELIS · VAXNEUVANCE · VYVANSE · Vyvanse · Xofluza · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pediatrics in FL.

Looking for a pediatrics specialist in Gulf Breeze?
Compare pediatricians in the Gulf Breeze area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
118
Per 100K population
60.9
County median income
$88,968
Nearest hospital
GULF BREEZE HOSPITAL
6.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reese is a pediatrics specialist, with low-engagement industry engagement in the top 6% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Reese receive payments from pharmaceutical companies?
Yes. Dr. Reese received a total of $2,485 from 25 companies across 145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Reese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatricians in Gulf Breeze
Browse pediatricians in Gulf Breeze ranked by procedure volume and transparency data.
Highest volume
Top Pediatricians in FL
Pediatricians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatricians in FL
Which FL pediatricians receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Neos Therapeutics, LP Payments to Doctors
See all physicians who received payments from Neos Therapeutics, LP.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →